Coastal Investment Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$13.02 - $20.31 $9,400 - $14,663	-722 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$16.88 - $20.83 $10,685 - $13,185	-633 Reduced 46.72%	722 $15,000
Q3 2019 Oct 18, 2019	SELL	$16.15 - $17.99 $5,862 - $6,530	-363 Reduced 21.13%	1,355 $24,000
Q2 2019 Aug 01, 2019	BUY	$16.58 - $20.49 $10,660 - $13,175	643 Added 59.81%	1,718 $32,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $17,952 - $23,134	1,075 New	1,075 $22,000

367

70.8M

3.3M

157K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.